<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Melanoma in a patient with DNMT3A overgrowth syndrome.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Melanoma in a patient with DNMT3A overgrowth syndrome." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240841/bin/MCS006267Che_F1.jpg"/> </div> <div class="text-side"> <h1>Melanoma in a patient with DNMT3A overgrowth syndrome.</h1> <p>Invasive melanoma in a DNMT3A overgrowth syndrome (DOS) patient. (A) Clinical appearance of a thin plaque with irregular borders and heterogeneous pigmentation on the left lateral neck. (B) Hematoxylin and eosin (H&amp;E)-stained (top) punch biopsy specimen consisting of atypical melanocytes with at the dermal–epidermal junction, as well as pagetoid spread and an invasive dermal component, measuring 1.3 mm in thickness (scale = 250 µm) with higher magnification of the invasive component with a mitotic cell highlighted by hollow red arrows (scale = 100 µm; boxed inset and lower left panel) and MART1 stain highlighting metastatic melanoma (solid red arrow) in the sentinel lymph node (scale = 50 µm; bottom right). Sequencing was performed on the other half of this bisected specimen. (C) DNMT3A variants in melanoma curated from cBioPortal (Cerami et al. 2012; Gao et al. 2013). Proband F414fs* germline mutation is notated with a star, whereas the acquired DNMT3AR749C melanoma mutation is additionally a mutation previously described in DOS patients.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37160317/" target="_blank">37160317</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>